Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human ...

Durham-based GeneCentric Therapeutics, a cancer diagnostics company, has closed on an $8 million round of venture capital to launch and commercialize a novel liquid biopsy platform for guiding ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Today marks International Women’s Day: a day devoted to celebrating women, their achievements and recognizing the bias that holds many back. Women in the Workplace 2020, a national report conducted by ...

North Carolina’s life sciences industry has crossed a milestone – exceeding 100,000 jobs for the first time – and continues to outpace national industry growth and most other top-tier life sciences ...

Merck has just disclosed plans to expand its hiring in Durham by 100 more employees in the next few years to hike output of a bladder cancer drug. As you walk through the imposing glass front entrance ...

URO-1, a Greensboro medical device company in prostate and soft tissue cancer diagnostics, has secured a new round of equity financing and announced additional milestones since the start of ...